Myriad Genetics, Inc. (MYGN) NASDAQ

6.55

-0.01(-0.15%)

Updated at December 24 01:00PM

Currency In USD

Valuation

Market Cap1.24B
Enterprise Value1.28B
P/E Ratio-1.52
PEG Ratio1.3
Price/Sales Ratio0.74
Price/Book Ratio1.64
Enterprise/Revenue0.82
Enterprise/EBITDA-1.87

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0.49
Operating Margin-0.51

Management Effectiveness

Return On Assets-0.55
Return On Equity-0.74

Income Statement

Revenue837.6M
Revenue/Share8.86
Gross Profit585.4M
EBITDA-59.5M
Net Income-127.3M
Diluted EPS-1.41

Balance Sheet

Total Cash145.4M
Total Cash/Share1.56
Total Debt212.3M
Total Debt/Equity0.57
Current Ratio2.33
Book Value Per Share4

Price History

52-Week Change-52.33
52-Week High15.47
52-Week Low3.76
Moving Average 50 Days7.26
Moving Average 200 Days6.62

Statistics

Average Volume1.1M
Shares Outstanding93.21M
% Held by Institutions95.7

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor2:1
Last Split DateMarch 26, 2009